On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Geyser Brands Inc. (TSX.V: GYSR) Generates First Revenues, Anticipates Receipt of Additional Health Canada Licenses

  • Geyser Brands’ first revenues of $79,434, generated during Q1 2019, represent a gross profit margin of 81 percent
  • The company is nearing final TSX Venture Exchange conditional approval of its transaction to acquire Solace Management Group Inc.
  • Geyser Brands subsidiary Apothecary Botanicals has received a standard processing license from Health Canada, which will allow the company to extend its CBD products to the regulated Canadian consumer medical market

Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company that builds and markets some of the world’s most loved cannabis products and brands, continues to achieve its stated strategic goals. Financial statements for the three months ended June 30, 2019, show Geyser Brands reporting revenues of $79,434, representing an 81 percent gross profit margin.

“We have begun to operationalize our manufacturing and processing capabilities, generating our first revenues during Q1. We are continuing to explore new brand opportunities and develop our manufacturing capacity to position the company for rapid expansion as our remaining Health Canada licenses get awarded,” CEO Andreas Thatcher stated in a news release (http://cnw.fm/Kl8Qm). “I am excited about the many opportunities that have been presented to us for producing and distributing hemp-based products on a global basis. We look forward to delivering additional, high-margin revenue streams once our R&D and sales licensing are in place.”

As a licensed producer in Canada under the Cannabis Act, Geyser operates a production and processing facility in Port Coquitlam, British Columbia, developing unique products for healthy lifestyle brands (http://cnw.fm/4leF5). The company’s wholly owned subsidiary, Apothecary Botanicals, recently received a standard processing license from Health Canada, which Thatcher characterized as “a huge milestone” for the company.

“The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD,” Thatcher stated in a news release (http://cnw.fm/qmQS3). “It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution for brand companies.”

An earlier announced acquisition of Solace Management Group Inc. is also moving ahead on target. Geyser Brands is working to provide the TSX Venture Exchange with the necessary documents and anticipates receipt of final approval shortly, the company stated. Solace, which carries a dynamic portfolio of both pet and consumer health care goods, is situated in a new, 7,500 square foot, GMP-compliant manufacturing facility, which is expected to increase production capacity of its hemp-related human and pet products by up to tenfold (http://cnw.fm/6sjLf).

Geyser Brands creates hemp and cannabis products and brands for the nutraceutical, cosmetics, food and beverage and pet sectors. Its proprietary nanotechnology formulation, termed ‘NanoFusion Technology’, solves the insolubility problem of most hemp and cannabis products with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency (http://cnw.fm/t8PWw).

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Archives

Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722